Literature DB >> 15346907

Advances in Kawasaki disease.

Stanford T Shulman1, Anne H Rowley.   

Abstract

UNLABELLED: Recent studies have increased our understanding of the etiopathogenesis of Kawasaki disease (KD). The inflammatory infiltrate in KD coronary artery aneurysms has been shown to consist of CD8 T lymphocytes, macrophages, and IgA plasma cells, consistent with an immune response to an intracellular pathogen with a mucosal portal of entry. The identification of an oligoclonal IgA response in the vascular wall and the detection of a KD-associated antigen in inflamed KD tissues using a synthetic antibody derived from KD oligoclonal IgA antibodies have provided new approaches to identification of the etiologic agent. Highly effective therapy has evolved for KD, even in the absence of identification of the etiologic agent. The existence of incomplete KD cases remains a significant diagnostic dilemma for the clinician.
CONCLUSION: The development of a diagnostic test, more specific therapy, and ultimate prevention of this potentially fatal illness of childhood are dependent upon continued advances in determining the etiopathogenesis of this fascinating disorder.

Entities:  

Mesh:

Year:  2004        PMID: 15346907     DOI: 10.1007/s00431-004-1431-z

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.860


  55 in total

1.  Incidence survey of Kawasaki disease in 1997 and 1998 in Japan.

Authors:  H Yanagawa; Y Nakamura; M Yashiro; I Oki; S Hirata; T Zhang; T Kawasaki
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

2.  Mucocutaneous lymph node syndrome in the United States.

Authors:  M E Melish; R M Hicks; E J Larson
Journal:  Am J Dis Child       Date:  1976-06

3.  Plasma exchange in Kawasaki disease.

Authors:  N Takagi; M Kihara; S Yamaguchi; K Tamura; M Yabana; Y Tokita; M Ishii
Journal:  Lancet       Date:  1995-11-11       Impact factor: 79.321

4.  Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease.

Authors:  Patrick J Gavin; Susan E Crawford; Stanford T Shulman; Francesca L Garcia; Anne H Rowley
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-06       Impact factor: 8.311

5.  Pathology of Kawasaki disease: II. Distribution and incidence of the vascular lesions.

Authors:  S Amano; F Hazama; Y Hamashima
Journal:  Jpn Circ J       Date:  1979-08

6.  Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome.

Authors:  M Linderholm; C Ahlm; B Settergren; A Waage; A Tärnvik
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

7.  Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.

Authors:  S Furukawa; T Matsubara; Y Umezawa; T Motohashi; T Ino; K Yabuta
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

8.  Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease.

Authors:  C Y Lin; C C Lin; B Hwang; B Chiang
Journal:  J Pediatr       Date:  1992-12       Impact factor: 4.406

9.  Kawasaki syndrome: description of two outbreaks in the United States.

Authors:  D M Bell; E W Brink; J L Nitzkin; C B Hall; H Wulff; I D Berkowitz; P M Feorino; R C Holman; C L Huntley; R H Meade; L J Anderson; S H Cheeseman; N J Fiumara; R F Gilfillan; D E Keim; J F Modlin
Journal:  N Engl J Med       Date:  1981-06-25       Impact factor: 91.245

10.  The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease.

Authors:  M Terai; K Miwa; T Williams; W Kabat; M Fukuyama; Y Okajima; H Igarashi; S T Shulman
Journal:  J Infect Dis       Date:  1995-08       Impact factor: 5.226

View more
  28 in total

Review 1.  Pediatric vasculitis.

Authors:  Ezgi Deniz Batu; Seza Ozen
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

2.  Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan.

Authors:  Daisuke Sudo; Yoshiro Monobe; Mayumi Yashiro; Makiko Naka Mieno; Ritei Uehara; Keiji Tsuchiya; Tomoyoshi Sonobe; Yosikazu Nakamura
Journal:  Eur J Pediatr       Date:  2011-12-10       Impact factor: 3.183

Review 3.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

4.  A randomized prospective study on the use of 2 g-IVIG or 1 g-IVIG as therapy for Kawasaki disease.

Authors:  Koichi Sakata; Kenji Hamaoka; Sei-Ichiro Ozawa; Ayumi Niboshi; Takao Yoshihara; Tesuo Nishiki; Yumi Nakagawa; Kikuko Kazuta; Yoshiko Morimoto; Yasutaka Kamiya; Toru Yamamoto; Yoshihiro Horii; Sachiko Kido
Journal:  Eur J Pediatr       Date:  2007-06       Impact factor: 3.183

5.  A 21-year-old male with reduced left ventricular function.

Authors:  Klaus Hertting; Jacobus Reimers; Karl-Heinz Kuck
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

6.  Shock following administration of contrast medium in a patient with Kawasaki disease.

Authors:  Toru Watanabe
Journal:  Pediatr Radiol       Date:  2010-02-17

7.  Kawasaki disease: unusual clinical manifestations.

Authors:  Lesa Dawman; S K Kabra
Journal:  Indian J Pediatr       Date:  2014-03-16       Impact factor: 1.967

8.  Affects of "age at diagnosis" on coronary artery lesions in patients with incomplete kawasaki disease.

Authors:  Min A Cho; Yeon Joo Choi; Jo Won Jung
Journal:  Korean Circ J       Date:  2010-06-29       Impact factor: 3.243

9.  Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.

Authors:  Yu Hirabayashi; Yoshiyuki Takahashi; Yinyan Xu; Kazuyuki Akane; Itzel Bustos Villalobos; Yusuke Okuno; Shinji Hasegawa; Hideki Muramatsu; Asahito Hama; Taichi Kato; Seiji Kojima
Journal:  Eur J Pediatr       Date:  2013-01-23       Impact factor: 3.183

10.  Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor.

Authors:  Yunku Yeo; TaeYeon Kim; KeeSoo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2008-05-14       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.